This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hastings, M. D.
Right arrow Articles by Sibley, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hastings, M. D.
Right arrow Articles by Sibley, C. H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2005, p. 733-740, Vol. 49, No. 2
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.2.733-740.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Novel Plasmodium vivax dhfr Alleles from the Indonesian Archipelago and Papua New Guinea: Association with Pyrimethamine Resistance Determined by a Saccharomyces cerevisiae Expression System

Michele D. Hastings,1 Jason D. Maguire,2 Michael J. Bangs,2,{dagger} Peter A. Zimmerman,3,4 John C. Reeder,4 J. Kevin Baird,2 and Carol Hopkins Sibley1*

Department of Genome Sciences, University of Washington, Seattle, Washington,1 The Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio,3 Parasitic Diseases Program, United States Naval Medical Research Unit 2, Jakarta, Indonesia,2 Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea4

Received 3 August 2004/ Returned for modification 16 September 2004/ Accepted 29 September 2004

In plasmodia, the dihydrofolate reductase (DHFR) enzyme is the target of the pyrimethamine component of sulfadoxine-pyrimethamine (S/P). Plasmodium vivax infections are not treated intentionally with antifolates. However, outside Africa, coinfections with Plasmodium falciparum and P. vivax are common, and P. vivax infections are often exposed to S/P. Cloning of the P. vivax dhfr gene has allowed molecular comparisons of dhfr alleles from different regions. Examination of the dhfr locus from a few locations has identified a very diverse set of alleles and showed that mutant alleles of the vivax dhfr gene are prevalent in Southeast Asia where S/P has been used extensively. We have surveyed patient isolates from six locations in Indonesia and two locations in Papua New Guinea. We sequenced P. vivax dhfr alleles from 114 patient samples and identified 24 different alleles that differed from the wild type by synonymous and nonsynonymous point mutations, insertions, or deletions. Most importantly, five alleles that carried four or more nonsynonymous mutations were identified. Only one of these highly mutant alleles had been previously observed, and all carried the 57L and 117T mutations. P. vivax cannot be cultured continuously, so we used a yeast assay system to determine in vitro sensitivity to pyrimethamine for a subset of the alleles. Alleles with four nonsynonymous mutations conferred very high levels of resistance to pyrimethamine. This study expands significantly the total number of novel dhfr alleles now identified from P. vivax and provides a foundation for understanding how antifolate resistance arises and spreads in natural P. vivax populations.

* Corresponding author. Mailing address: Department of Genome Sciences, Box 357730, University of Washington, Seattle, WA 98195-7730. Phone: (206) 685-9378. Fax: (206) 543-0754. E-mail: sibley{at}gs.washington.edu.

{dagger} Present address: Navy Disease Vector Ecology and Control Center, Silverdale, WA 98315-0304.

Antimicrobial Agents and Chemotherapy, February 2005, p. 733-740, Vol. 49, No. 2
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.2.733-740.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Rungsihirunrat, K., Sibley, C. H., Mungthin, M., Na-Bangchang, K. (2008). Geographical Distribution of Amino Acid Mutations in Plasmodium vivax DHFR and DHPS from Malaria Endemic Areas of Thailand. Am J Trop Med Hyg 78: 462-467 [Abstract] [Full Text]  
  • Marfurt, J., Mueller, I., Sie, A., Maku, P., Goroti, M., Reeder, J. C., Beck, H.-P., Genton, B. (2007). Low Efficacy of Amodiaquine or Chloroquine Plus Sulfadoxine-Pyrimethamine against Plasmodium falciparum and P. vivax Malaria in Papua New Guinea. Am J Trop Med Hyg 77: 947-954 [Abstract] [Full Text]  
  • Edstein, M. D., Kotecka, B. M., Ager, A. L., Smith, K. S., DiTusa, C. A., Diaz, D. S., Kyle, D. E., Schiehser, G. A., Jacobus, D. P., Rieckmann, K. H., O'Neil, M. T. (2007). Antimalarial pharmacodynamics and pharmacokinetics of a third-generation antifolate JPC2056 in cynomolgus monkeys using an in vivo in vitro model. J Antimicrob Chemother 60: 811-818 [Abstract] [Full Text]  
  • RUNGSIHIRUNRAT, K., NA-BANGCHANG, K., HAWKINS, V. N., MUNGTHIN, M., SIBLEY, C. H. (2007). SENSITIVITY TO ANTIFOLATES AND GENETIC ANALYSIS OF PLASMODIUM VIVAX ISOLATES FROM THAILAND. Am J Trop Med Hyg 76: 1057-1065 [Abstract] [Full Text]  
  • Alam, M. T., Bora, H., Bharti, P. K., Saifi, M. A., Das, M. K., Dev, V., Kumar, A., Singh, N., Dash, A. P., Das, B., Wajihullah, , Sharma, Y. D. (2007). Similar Trends of Pyrimethamine Resistance-Associated Mutations in Plasmodium vivax and P. falciparum. Antimicrob. Agents Chemother. 51: 857-863 [Abstract] [Full Text]  
  • AULIFF, A., WILSON, D. W., RUSSELL, B., GAO, Q., CHEN, N., ANH, L. N., MAGUIRE, J., BELL, D., O'NEIL, M. T., CHENG, Q. (2006). AMINO ACID MUTATIONS IN PLASMODIUM VIVAX DHFR AND DHPS FROM SEVERAL GEOGRAPHICAL REGIONS AND SUSCEPTIBILITY TO ANTIFOLATE DRUGS.. Am J Trop Med Hyg 75: 617-621 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»